SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
SUPN on Nasdaq
Shares outstanding
57,709,383
Price per share
$49.70
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
57,682,442
Total reported value
$2,756,480,707
% of total 13F portfolios
0%
Share change
-1,915,486
Value change
-$55,647,987
Number of holders
306
Price from insider filings
$49.70
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $260,337,450 8,197,023 BlackRock, Inc. 31 Mar 2025
ARMISTICE CAPITAL, LLC 5.1% -47% $135,532,440 -$112,784,400 2,836,000 -45% Armistice Capital, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 4.7% $134,803,348 2,712,341 Dimensional Fund Advisors LP 31 Dec 2025

As of 30 Sep 2025, 306 institutional investors reported holding 57,682,442 shares of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN). This represents 100% of the company’s total 57,709,383 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 8,698,410 -7.1% 0.01% $415,697,015
VANGUARD GROUP INC 10% 6,044,750 -2.6% 0% $288,878,603
DIMENSIONAL FUND ADVISORS LP 5.2% 3,001,941 -0.64% 0.03% $143,461,695
ARMISTICE CAPITAL, LLC 4.9% 2,836,000 -41% 4.3% $135,532,440
MACQUARIE GROUP LTD 4.4% 2,531,537 -8.3% 0.14% $120,982,000
STATE STREET CORP 3.8% 2,187,560 -0.95% 0% $104,543,492
Point72 Asset Management, L.P. 3.1% 1,761,484 +247% 0.18% $84,181,320
RENAISSANCE TECHNOLOGIES LLC 3% 1,740,622 +5.2% 0.11% $83,184,325
CITADEL ADVISORS LLC 2.5% 1,416,926 +709% 0.05% $67,714,893
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,410,024 +0.74% 0% $67,394,944
Stephens Investment Management Group LLC 2.3% 1,345,402 -15% 0.83% $64,296,762
LOOMIS SAYLES & CO L P 2.2% 1,285,937 -0.92% 0.07% $61,454,929
Woodline Partners LP 2.2% 1,263,811 +63% 0.28% $60,397,528
GOLDMAN SACHS GROUP INC 2% 1,163,058 +30% 0.01% $55,582,542
GW&K Investment Management, LLC 1.9% 1,080,538 -15% 0.46% $51,639,000
D. E. Shaw & Co., Inc. 1.7% 979,604 +64% 0.04% $46,815,276
BANK OF AMERICA CORP /DE/ 1.5% 842,890 +67% 0% $40,281,713
MORGAN STANLEY 1.3% 755,317 +8.9% 0% $36,096,650
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 732,489 -2.2% 0.01% $35,005,649
NORTHERN TRUST CORP 1.2% 703,555 -0.96% 0% $33,622,894
Rubric Capital Management LP 1% 595,366 -14% 0.38% $28,452,541
ASHFORD CAPITAL MANAGEMENT INC 0.98% 563,718 -1.9% 3% $26,940,083
VICTORY CAPITAL MANAGEMENT INC 0.97% 559,835 -26% 0.02% $26,754,515
UBS Group AG 0.94% 540,123 +138% 0.01% $25,812,478
AMERICAN CENTURY COMPANIES INC 0.88% 509,368 -44% 0.01% $24,342,697

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 566,877 $28,174,648 +$13,730,178 $49.70 32
2025 Q3 57,682,442 $2,756,480,707 -$55,647,987 $47.79 306
2025 Q2 59,473,450 $1,874,807,260 +$9,630,449 $31.52 292
2025 Q1 59,101,587 $1,935,401,832 -$15,482,542 $32.75 288
2024 Q4 59,487,738 $2,151,320,711 -$16,150,270 $36.16 289
2024 Q3 59,707,899 $1,861,669,268 +$51,576,538 $31.18 268
2024 Q2 58,411,043 $1,562,706,979 +$37,752,116 $26.75 242
2024 Q1 56,457,798 $1,925,433,109 -$17,095,923 $34.11 247
2023 Q4 122,487 $3,544,774 +$2,186,301 $28.94 1
2023 Q3 56,662,318 $1,562,169,072 -$16,794,382 $27.57 234
2023 Q2 56,852,221 $1,709,062,413 +$25,985,035 $30.06 242
2023 Q1 55,269,978 $2,002,413,184 -$15,708,258 $36.23 253
2022 Q4 55,832,866 $1,992,070,784 +$9,204,438 $35.67 257
2022 Q3 53,196,234 $1,800,650,479 +$13,831,364 $33.85 232
2022 Q2 54,214,452 $1,567,951,015 +$43,409,704 $28.92 212
2022 Q1 53,498,703 $1,728,115,579 -$41,228,689 $32.32 218
2021 Q4 54,613,858 $1,591,597,475 +$20,486,845 $29.16 223
2021 Q3 54,377,224 $1,451,012,413 +$2,475,554 $26.67 217
2021 Q2 53,930,281 $1,660,103,127 +$28,547,254 $30.79 220
2021 Q1 53,141,993 $1,391,977,874 +$12,158,270 $26.18 218
2020 Q4 52,790,254 $1,328,512,761 +$29,260,671 $25.16 218
2020 Q3 50,435,442 $1,051,038,929 +$15,969,813 $20.84 201
2020 Q2 50,272,297 $1,193,887,920 +$47,051,989 $23.75 211
2020 Q1 47,467,825 $853,864,986 -$50,738,159 $17.99 191
2019 Q4 50,459,665 $1,196,854,651 +$9,106,955 $23.72 225
2019 Q3 50,225,195 $1,380,066,892 -$77,516,067 $27.48 232
2019 Q2 51,486,121 $1,703,223,467 +$15,868,406 $33.09 262
2019 Q1 52,966,568 $1,855,764,308 +$39,997,805 $35.04 279
2018 Q4 51,181,080 $1,699,918,218 -$14,292,115 $33.22 261
2018 Q3 51,496,884 $2,592,246,088 -$111,496,495 $50.35 279
2018 Q2 53,354,158 $3,190,192,375 +$187,275,624 $59.85 313
2018 Q1 51,233,650 $2,342,561,330 +$81,611,000 $45.80 305
2017 Q4 49,629,256 $1,978,983,393 -$48,640,691 $39.85 290
2017 Q3 50,806,897 $2,032,970,440 +$95,437,423 $40.00 271
2017 Q2 46,945,086 $2,022,808,513 +$104,710,332 $43.10 259
2017 Q1 46,039,744 $1,441,049,341 +$218,442,368 $31.30 240
2016 Q4 45,276,845 $1,143,045,006 -$18,504,802 $25.25 226
2016 Q3 45,979,936 $1,134,457,536 -$8,992,041 $24.73 216
2016 Q2 46,043,096 $938,002,508 +$63,278,671 $20.37 207
2016 Q1 44,607,131 $680,212,121 +$7,457,207 $15.25 205
2015 Q4 44,627,700 $600,315,907 -$43,219,483 $13.44 203
2015 Q3 46,847,791 $657,293,219 +$61,822,268 $14.03 179
2015 Q2 42,084,293 $714,575,662 +$79,096,714 $16.98 161
2015 Q1 40,410,231 $488,466,846 +$44,987,379 $12.09 115
2014 Q4 37,070,882 $307,725,828 +$10,654,715 $8.30 105
2014 Q3 35,506,240 $308,535,879 -$18,049,211 $8.69 92
2014 Q2 36,998,689 $403,987,758 +$41,930,489 $10.95 85
2014 Q1 33,371,068 $298,265,368 +$21,603,263 $8.94 81